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The effects of manno-1-deoxynojirimycin (ManDJN) and 2,5-dihydroxymethyl-3,4_dihydroxypyrrolidine 
(DMDP) were compared in IEC-6 intestinal epithelial cells in culture. ManDJN caused complete inhibition 
of N-linked complex oligosaccharide synthesis whereas a maximum of 80% inhibition was obtained with 
DMDP. HPLC showed similar endo H-sensitive oligosaccharides for control and treated cells. ManDJN 
caused a large increase in the levels of labeled Man,_s GlcNAc and a decrease in MansGlcNAc. DMDP 
produced similar changes except hat the increase in Man,_sGlcNAc was less pronounced and some increase 
in glucosylated oligosaccharides was observed. Since the major oligosaccharides found in DMDP-treated 
cells were non-glucosylated, its primary effect on complex oligosaccharide synthesis not due to inhibition 
of glucosidases, in contrast o what has been reported for influenza virus-infected MDCK cells [(1984) J.
Biol. Chem. 259, 1240!%12413]. 
Manno-I-deoxynojirimycin 2,5-Dihydroxymethyl-3,4-dihydroxypyrrolidine 
Glycoprotein synthesis 
Processing inhibitor 
1. INTRODUCTION thesis of N-linked complex oligosaccharides [2-61. 
Compounds which can modify the structure of 
carbohydrates are useful to elucidate their function 
on glycoproteins. The N-linked oligosaccharides 
consist of high mannose, complex and hybrid 
structures which all arise from processing of the 
common precursor, GlcsMansGlcNAcz. Both CY- 
glucosidases and a-mannosidases are involved in 
the first steps of processing [l]. Inhibitors of these 
enzymes have been shown to prevent the biosyn- 
Recently, two novel inhibitors of complex 
oligosaccharide biosynthesis were described: the 
mannose analog of DJN, ManDJN, was found to 
inhibit mu-mannosidase I [7,14]; and the pyrrolidine 
alkaloid, DMDP, was reported to prevent the ac- 
tion of glucosidase I [8]. 
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Abbreviations: DJN, I-deoxynojirimycin; DMDP, 
2[R],5[R]-dihydroxymethyl-3[R],4[R]-dihydroxypyrroli- 
dine; ManDJN, l ,S-dideoxy-1,5-imino-D-mannitol 
(manno-1-deoxynojirimycin); MDJN, N-methyl-l-de- 
oxynojirimycin; endo H, endo-,&N-acetylglucosamini- 
dase H 
In previous work we demonstrated that DJN 
and MDJN inhibit processing glucosidases and 
prevent the synthesis of N-linked complex 
oligosaccharides in intestinal epithelial cells in 
culture [3,9, lo]. Fractionation by HPLC 
demonstrated that a mixture of glucosylated high 
mannose oligosaccharides containing l-3 glucose 
residues and 7-9 mannose residues accumulate in 
the presence of these inhibitors, and that a much 
larger proportion of these oligosaccharides con- 
tained 3 glucose residues in the presence of MDJN 
than with DJN [lo]. 
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Here, we compare the effects of ManDJN and 
DMDP on glycosylation in intestinal epithelial 
cells with those obtained previously with DJN and 
MDJN. Of these 4 compounds, ManDJN is the on- 
ly one which causes complete inhibition of com- 
plex chain synthesis; in its presence only high man- 
nose oligosaccharides are formed, and there is a 
large increase in Man,-9GlcNAc species. DMDP 
inhibits complex chain formation to about the 
same extent as DJN and MDJN, but the major 
oligosaccharides formed in its presence are non- 
glucosylated high mannose oligosaccharides, in 
contrast to the results reported in MDCK cells in- 
fected with influenza virus [8]. 
2. MATERIALS AND METHODS 
The source of chemicals was described previous- 
ly [lo]. ManDJN was obtained from Dr G. Kinast, 
Bayer AG, Wuppertal, FRG. DMDP was isolated 
from the seeds of Lo~chocar~us sericeus 11 l], and 
was shown by ‘H-NMR to have the reported struc- 
ture [12]. 
The methods used were all described previously 
[3,10]. Confluent IEC-6 rat intestinal epithelial 
cells were incubated for 24 h with 10 &i/ml of D- 
[Z3H]mannose, and labeled glycopeptides ob- 
tained by exhaustive pronase digestion were frac- 
tionated on Bio-Gel P-6, before and after endo H 
treatment to separate glycopeptides containing 
complex oligosaccharides from high mannose 
oligosaccharides. The high mannose oligosac- 
charides were further fractionated by HPLC with 
[ 14C]glucose-labeled standards, before and after 
exhaustive jack bean cr-mannosidase digestion. 
3. RESULTS 
3.1. Effect of the inhibitors on g~ycosy~ation 
The effects of ManDJN and DMDP on 
glycoprotein biosynthesis in IEC-6 cells were ex- 
amined after labeling with D-[2-3H]mannose under 
the conditions used previously with DJN and 
MDJN [IO]. ManDJN completely inhibited the in- 
corporation of labeled mannose into glycopeptides 
containing complex oligosaccharides and greatly 
increased (2.4 fold) the labeling of the high man- 
nose oligosaccharides (fig.lA,B). Similarly, the in- 
corporation of labeled mannose into complex 
oligosaccharides was greatly inhibited by 5 mM 
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Fig. 1. Effects of ManDJN and DMDP on glycopeptides 
IEC-6 cells labeled with D-[2-3H]mannose. Labeled 
glycopeptides obtained by exhaustive pronase digestion 
were first fractionated on a column of Bio-Gel P-6 (not 
shown). The labeled glycopeptides were then incubated 
with endo H as described under section 2, and the 
products chromatographed on the same column of Bio- 
Gel P-6. Endo H treatment did not affect the elution of 
glycopeptides with Kay = 0.3 and caused a change in 
elution of glycopeptides (Z& = 0.45) to oligosaccharides 
(Kav = 0.6) found in fractions 70-90. (A) Control cells, 
(B) cells treated with 2.0 mM ManDJN, (C) cells treated 
with 5.0 mM DMDP. 
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DMDP (fig.lC), while the labeling of the high 
mannose oligosaccharides was increased (about 
75%). The maximum inhibition of complex 
oligosaccharide synthesis was 80~0 and was never 
complete even if the concentration of DMDP was 
increased to 10 mM. Neither compound inhibited 
the formation of GlcJMangGlcNAcz-PP-dolichol 
pyrophosphate, in marked contrast to the inhibi- 
tion observed with DJN [13]. 
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Fig.2. HPLC of endo H-sensitive oligosaccharides. The 
labeled oligosaccharides (Kav = 0.6) released by endo H 
obtained from Bio-Gel P-6 (fig-l) were fractionated by 
HPLC as described under section 2. (A) Control cells, 
(B) cells treated with 2.0 mM ManDJN, (C) cells treated 
with 5 mM DMDP. The arrows indicate the elu- 
tion position of “C-labeled standards: Glcr , 
GlcrMangGlcNAc; Glc2, Glc2MangGlcNAc; Glc3, 
Glc3MangGlcNAc. I, MangGlcNAc; II, MansGlcNac; 
III, MamGIcNAc; IV, Man6GlcNac; V, MansGlcNAc. 
3.2. HPLC of the oligosaccharides 
The endo H released oligosaccharides were frac- 
tionated by HPLC. The patterns of oligosac- 
charides obtained from control and treated cells 
were similar; the major oligosaccharides cor- 
responded in elution to Mans-9GlcNAc with only 
a small proportion eluting with the glucosylated 
standards (fig.2). The presence of ManDJN caused 
a large increase in labeled Man,GlcNAc (3.6 fold), 
MansGlcNAc (2.7 fold) and MansGlcNAc 
(2.6 fold), little change in MansGlcNAc and a 
decrease (5OOro) in MansGlcNAc. Similar results 
were obtained for ManDJN concentrations be- 
tween 2.0 and 4.0 mM. With DMDP similar 
changes in the oligosac~harides were observed, ex- 
cept that the increase in ManTGlcNAc, 
MansGlcNAc and MangGlcNAc was less pro- 
nounced, and some increase in oligosaccharides 
eluting with the glucosylated standards was ob- 
served. When the concentration of DMDP was in- 
creased from 5 to 10 mM, there was a further in- 
crease in the glucosylated oligosaccharide species, 
but the inhibition of complex oligosaccharide syn- 
thesis remained about the same. 
To confirm that the majority of the labeled 
oligosaccharides were non-glucosylated high man- 
nose species, they were exhaustively digested with 
jack bean a-mannosidase, and the products were 
fractionated by HPLC. For control and ManDJN- 
treated cells, cu-mannosidase r leased almost all the 
radioactivity (96-98%) in the mannose-containing 
fraction (table l), as expected for non-glucosylated 
high mannose oligosaccharides. For DMDP- 
treated cells, a similar treatment released slightly 
less radioactivity (about 85%), and a small propor- 
tion of radioactivity was recovered in 
Glct-3MamGlcNAc oligosaccharides. For com- 
parison the results obtained previously [lo] for a 
similar cu-mannosidase treatment of the oligosac- 
charides formed in the presence of the glucosidase 
inhibitor MDJN are shown in table 1. In this case, 
less than 50% of the radioactivity was released as 
mannose by a-mannosidase, and a major propor- 
tion of the radioactivity was recovered in 
Glc~Ma~GlcNA~. 
4. DISCUSSION 
The above results demonstrate that ManDJN 
causes a much more complete inhibition of N- 
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Table 1 
Products of cx-mannosidase treatment of oligosaccharides 
Additions Concentration 
(mM) 
GICla Glcz” Glc3= 
(dpm (070)) 
Mannoseb 
May 1985 
None 110 (4) - 2880 (96) 
ManDJN 2.0 60 (2) - 2950 (98) 
DMDP 5.0 65 (4) 75 (4) lOO( 5) 1600 (87) 
MDJN 2.0 570 (7) 555 (7) 3220 (41) 3490 (45) 
a Glct = GlciMaILzGlcNAc, Glcz = GlczMan4GlcNAc, Glo = Glc3Man4GlcNAc 
b Under these conditions mannose and Mar@ --+4GlcNAc disaccharide are not resolved 
Endo H-sensitive oligosaccharides obtained after Bio-Gel P-6 chromatography (fig. 1) were 
treated with jack bean ~-mannosidase and fractionated by HPLC 
linked complex oligosaccharide synthesis in IEC-6 
cells than either DJN, MDJN or DMDP. In its 
presence, the major oligosaccharides, which ac- 
count for 86% of the labeled oligosaccharides, are 
Man,GlcNAc, MansGlcNAc and MansGlcNAc. 
These results agree with those obtained in other 
cells [7]. It was reported recently that ManDJN is 
a specific inhibitor of rat liver Golgi cr- 
mannosidase I, and has no effect on the RER a- 
mannosidase [ 141 which can utilize Map-9GlcNAc 
oligosaccharides as substrates [ 151. It is likely, 
therefore, that the removal of mannose residues 
observed in the presence of ManDJN in vivo is due 
to RER a-mannosidase activity. Studies in other 
cells have demonstrated that processing to 
ManeGlcNAc and even to M~sGlcNAc can occur 
in the RER [16-191. 
DMDP inhibits the synthesis of complex 
oligosaccharides in IEC-6 cells to about the same 
extent as was previously observed for DJN and 
MDJN [3,10]. In these cells, a mixture of high 
mannose oligosaccharides is found after DMDP 
treatment, with an increase in the relative propor- 
tions of Man,_9GlcNAc which account for 67(rlo f 
the labeled oligosaccharides. There is also a small 
increase in glucosylated oligosaccharides, but this 
increase cannot account for the observed inhibi- 
tion of complex oligosaccharide formation. In 
fact, the pattern of oligosaccharides formed in the 
presence of DMDP is very different from that ob- 
tained in the presence of the glucosidase inhibitors 
DJN and MDJN [IO], and much more similar to 
that found in control and ManDJN-treated cells. It 
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is concluded that the primary effect of DMDP on 
complex oligosaccharide synthesis does not result 
from inhibition of the glucosidases. DMDP may 
be acting by inhibiting processing ~-mannosidases, 
or may have some other effect. The results de- 
scribed with DMDP in IEC-6 cells differ from 
those obtained in influenza virus-infected MDCK 
cells [8] in which the major oligosaccharides were 
identified as GlsMans-gGlcNAc, and the effect of 
DMDP on glycosylation was ascribed to inhibition 
of glucosidase I. The reasons for this difference in 
the action of DMDP in the intestinal epithelial cells 
and in MDCK cells are unclear, and remain to be 
elucidated. 
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